Dr. Robert G. Bota, MD

Dr. Bota practices at Brainhealth Solutions, Inc. in Costa Mesa, California.

Dr. Bota's NPI, 1407990773, was assigned on February 19, 2007. Dr. Bota graduated from Carol Davila University of Medicine and Pharmacy in 1997. Dr. Bota's California license number on file is A103585.

Dr. Bota's primary practice is Brainhealth Solutions, Inc., at 3151 Airway Ave, Costa Mesa, CA 92626 in Orange County. The practice phone is (949) 288-5377.

Dr. Bota's primary practice is Brainhealth Solutions, Inc. in Costa Mesa, California. Dr. Bota is also affiliated with College Medical Center. The medical group on file is Harbor Psychiatry & Mental Health. Dmand AI also links Dr. Bota to 5 more medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bota practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Bota's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Bota is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bota's licenses on file in 4 states: California, Arizona, Georgia and North Carolina.

Dmand AI lists anxiety, bipolar disorder, depression, insomnia and schizophrenia among the conditions Dr. Bota treats.

CMS data shows 1,120 Medicare services from Dr. Bota across 6 procedure codes in 2024, for 80 Medicare patients. Medicare paid $114,098 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Bota in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have anxiety, and 75% have depression. 33% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bota's median patient age at 41, with 51% women.

In 2024, Dr. Bota wrote 318 Medicare Part D claims for 40 patients. 88% of them were for generic drugs. CMS names the drug for 196 of them, across 11 drugs with 11 or more claims each, at $8,203 in total drug cost. In 2023, CMS named 242 claims across 12 drugs.

Dr. Bota accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Dr. Bota, published from 2012 to 2021. 2017 was the busiest year, with 5. The most frequent topics are Schizophrenia, Schizophrenic Psychology and Antipsychotic Agents. Dr. Bota has published most often in Ment Illn. Dr. Bota's most frequent co-authors are Andrei Novac, MD, John Nathaniel Alvarez and Todd Ramsey Wojtanowicz, MD.

Dmand AI links Dr. Bota to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Depressive Disorder, Treatment-Resistant, Stress Disorders, Post-Traumatic and Depressive Disorder, Major. Open Payments lists research payments to Dr. Bota that name 1 trial.

CMS Open Payments shows 48 general payments to Dr. Bota from 20 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $594. It also lists 7 research payments totaling $1,617 in 2020, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Bota, most recently Distinguished Fellow of American Psychiatric Association in 2016.

Dr. Bota graduated from Carol Davila University of Medicine and Pharmacy in 1997. Dr. Bota is a member of American Association for the Advancement of Science, APA and Clinical TMS Ssociety.

Dr. Bota is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.